The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patterns of metastases, treatment (tx), and outcomes in bone predominant (BP) metastatic urothelial carcinoma (mUC).
 
Ariel Ann Nelson
No Relationships to Disclose
 
Aman Opneja
No Relationships to Disclose
 
Behtash Ghazi Nezami
No Relationships to Disclose
 
Lee Evan Ponsky
No Relationships to Disclose
 
Matthew David Wright
No Relationships to Disclose
 
Patrick Mergler
Consulting or Advisory Role - Carevive Systems
Patents, Royalties, Other Intellectual Property - Utility Patent, US application 14/988,132 (Pending). "Systems and Methods for matching patients with clinical trials"; Utility Patent, US application 15/625,697 (pending). "Monitoring and evaluating patient reactions to medications"
 
Ravi Kumar Kyasaram
No Relationships to Disclose
 
Cheryl Eitman
No Relationships to Disclose
 
Krupen Patel
No Relationships to Disclose
 
Gregory MacLennan
No Relationships to Disclose
 
Matthew M. Cooney
Consulting or Advisory Role - Bayer
Speakers' Bureau - Potomac Center for Medical Education
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Biocept; Bristol-Myers Squibb; Clovis Oncology; Dendreon; Driver, Inc; EMD Serono; Exelixis; Foundation Medicine; Genentech; Merck; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Genentech
Research Funding - AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)
 
Pedro C. Barata
No Relationships to Disclose
 
Jorge A. Garcia
Consulting or Advisory Role - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation; Pfizer; Sanofi
Speakers' Bureau - Bayer; Genentech/Roche; Medivation/Astellas; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Orion (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation/Astellas; Pfizer; Sanofi
 
Pingfu Fu
No Relationships to Disclose
 
Christopher J. Hoimes
Honoraria - Seagen
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Foundation Medicine; Genentech/Roche; Prometheus; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Genentech/Roche
Research Funding - Merck Sharp & Dohme